Adjuvant therapy in colon cancer: current status and future directions, Cancer Treatment Reviews, vol.28, issue.5, pp.223-236, 2002. ,
DOI : 10.1016/S0305-7372(02)00047-6
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer, J Clin Oncol, pp.18-2938, 2000. ,
Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial, Lancet, pp.355-1041, 2000. ,
Resistance to 5-Fluorouracil, General Pharmacology: The Vascular System, vol.31, issue.5, pp.31-661, 1998. ,
DOI : 10.1016/S0306-3623(98)00191-8
Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro, Biochem Pharmacol, vol.54, pp.1233-1242, 1997. ,
5-Fluorouracil: mechanisms of action and clinical strategies, Nature Reviews Cancer, vol.3, issue.5, pp.330-338, 2003. ,
DOI : 10.1038/nrc1074
Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol.1587, issue.2-3, pp.1587-194, 2002. ,
DOI : 10.1016/S0925-4439(02)00082-0
Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR, Jpn J Cancer Res, pp.93-1342, 2002. ,
Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidinebased chemotherapy for metastatic colorectal cancer, Clin Cancer Res, vol.9, pp.786-791, 2003. ,
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase, Clin Cancer Res, vol.6, pp.1322-1327, 2000. ,
Tumoral-reduced folates and clinical resistance to fluorouracil-based treatment in head and neck cancer patients, J Clin Oncol, vol.15, pp.2604-2610, 1997. ,
Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data, Clin Cancer Res, vol.3, pp.553-557, 1997. ,
Prognostic significance of the thymidylate biosynthetic enzymes in human colorectal tumors, Oncology, pp.62-167, 2002. ,
Molecular cloning and expression of rat V1a and V2 arginine vasopressin receptors, Regulatory Peptides, vol.45, issue.1-2, pp.356-523, 1992. ,
DOI : 10.1016/0167-0115(93)90182-8
Sensitivity and accuracy of quantitative real-time polymerase chain reaction using SYBR green I depends on cDNA synthesis conditions, Anal Biochem, pp.307-63, 2002. ,
Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene, Nucleic Acids Research, vol.13, issue.7, pp.13-2485, 1985. ,
DOI : 10.1093/nar/13.7.2485
Development and validation of realtime quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro, Anal Biochem, pp.270-311, 1999. ,
Gene expression in colorectal cancer and in vitro chemosensitivity to 5-fluorouracil: a study of 88 surgical specimens, Cancer Sci, pp.94-633, 2003. ,
Evaluation of standard tyrosinase RT-PCR in melanoma patients by the use of the LightCycler system, Clin Chim Acta, pp.306-133, 2001. ,
Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer, J Clin Oncol, pp.20-1735, 2002. ,
Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients, Br J Cancer, pp.82-560, 2000. ,
Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil, European Journal of Cancer, vol.40, issue.7, pp.40-939, 2004. ,
DOI : 10.1016/j.ejca.2003.12.004
The changes in the levels of dihydrofolate reductase mRNA and its gene dosage in 5-fluorouracil-resistant L1210 cells., The Tohoku Journal of Experimental Medicine, vol.161, issue.1, pp.161-194, 1990. ,
DOI : 10.1620/tjem.161.33
Decreased folylpolyglutamate synthetase expression: a novel mechanism of fluorouracil resistance, Cancer Res, pp.53-3677, 1993. ,
Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients, Clin Cancer Res, vol.9, pp.6012-6019, 2003. ,
Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours, Br J Cancer, vol.77, pp.461-465, 1998. ,
Dihydropyrimidine dehydrogenase activity of cancerous and non-cancerous tissues in liver and large intestine, Oncology Reports, vol.8, pp.621-625, 2001. ,
DOI : 10.3892/or.8.3.621
Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer, The Lancet, vol.355, issue.9217, pp.355-1745, 2000. ,
DOI : 10.1016/S0140-6736(00)02261-3
Gender differences in the dihydropyrimidine dehydrogenase expression of colorectal cancers, Cancer Lett, vol.188, pp.231-236, 2002. ,
Tumor dihydropyrimidine dehydrogenase in stage II and III colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone, Cancer Lett, pp.204-97, 2004. ,
Folate status: effects on pathways of colorectal carcinogenesis ,
Folate and chemoprevention of colorectal cancer: is 5-methyl-tetrahydrofolate an active antiproliferative agent in folate-treated colon-cancer cells?, Nutrition, vol.17, issue.7-8, pp.17-652, 2001. ,
DOI : 10.1016/S0899-9007(01)00594-9
Folic acid inhibition of EGFR-mediated proliferation in human colon cancer cell lines, Am J Physiol, pp.277-1142, 1999. ,
Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study, J Pediatr Hematol Oncol, pp.25-688, 2003. ,
Characterization of p53 Wild-Type and Null Isogenic Colorectal Cancer Cell Lines Resistant to 5-Fluorouracil, Oxaliplatin, and Irinotecan, Clinical Cancer Research, vol.10, issue.6, pp.10-2158, 2004. ,
DOI : 10.1158/1078-0432.CCR-03-0362
Predicting 5-FU sensitivity using human colorectal cancer specimens: comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU, International Journal of Clinical Oncology, vol.7, issue.6, pp.335-342, 2002. ,
DOI : 10.1007/s101470200051